Literature DB >> 10450428

Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections.

T Smith1, I Felger, M Tanner, H P Beck.   

Abstract

Epidemiological studies of multiple clone infections by Plasmodium falciparum in highly endemic areas have demonstrated age dependence in both the multiplicity of infection and the relationships between this multiplicity and the risk of acute illness. We hypothesize that, in infants, host defence against blood-stage infections with P. falciparum relies mainly on fever and cytokine activities, and the infections are of short duration. In older children, a high multiplicity of infection is characteristic of low-level chronic parasitaemia. This appears to confer cross-protection against newly inoculated parasites, via partially genotype-specific responses which are short-term, lasting little longer than the infections themselves. This has important implications for our understanding of immunity against P. falciparum, its ecological niche, and the epidemiological impact of interventions against it.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450428     DOI: 10.1016/s0035-9203(99)90329-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  73 in total

1.  Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria.

Authors:  Ton That Ai Long; Shusuke Nakazawa; Maria Cecilia Huaman; Hiroji Kanbara
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites.

Authors:  Silvie Huijben; William A Nelson; Andrew R Wargo; Derek G Sim; Damien R Drew; Andrew F Read
Journal:  Evolution       Date:  2010-08-19       Impact factor: 3.694

3.  Malaria in a holoendemic area of Burkina Faso: a cross-sectional study.

Authors:  August Stich; Nadja Oster; Inas Z Abdel-Aziz; Gabriele Stieglbauer; Boubacar Coulibaly; Hannes Wickert; Jeremy McLean; Bocar A Kouyaté; Heiko Becher; Michael Lanzer
Journal:  Parasitol Res       Date:  2006-01-14       Impact factor: 2.289

4.  The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.

Authors:  S Huijben; D G Sim; W A Nelson; A F Read
Journal:  J Evol Biol       Date:  2011-08-23       Impact factor: 2.411

5.  The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy.

Authors:  Andrew F Read; Troy Day; Silvie Huijben
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

6.  Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon.

Authors:  Benjamin J Visser; Sophia G de Vries; Rieke Vingerling; Martin Gritter; Danielle Kroon; Lídia Ciudad Aguilar; Rik B J Kraan; Rosanne W Wieten; François Danion; Barbara Sjouke; Akim A Adegnika; Selidji T Agnandji; Peter G Kremsner; Thomas Hänscheid; Petra F Mens; Michèle van Vugt; Martin P Grobusch
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

7.  Mathematical illiteracy impedes progress in biology.

Authors:  Nakul Chitnis; Thomas A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-20       Impact factor: 11.205

8.  Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.

Authors:  Nickolay Neznanov; Anton V Gorbachev; Lubov Neznanova; Andrei P Komarov; Katerina V Gurova; Alexander V Gasparian; Amiya K Banerjee; Alexandru Almasan; Robert L Fairchild; Andrei V Gudkov
Journal:  Cell Cycle       Date:  2009-12-25       Impact factor: 4.534

Review 9.  Gametocytes: insights gained during a decade of molecular monitoring.

Authors:  Hamza A Babiker; Petra Schneider; Sarah E Reece
Journal:  Trends Parasitol       Date:  2008-09-16

10.  Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.

Authors:  Matthew Cairns; Roly Gosling; Ilona Carneiro; Samwel Gesase; Jacklin F Mosha; Ramadhan Hashim; Harparkash Kaur; Martha Lemnge; Frank W Mosha; Brian Greenwood; Daniel Chandramohan
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.